Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women

Clinical Nutrition

Volumn 32, Issue 6, 2013, Pages 1017-1022

  Teixeira, T F S ^a   Grześkowiak, Łukasz M ^a,b   Salminen, Seppo ^b   Laitinen, Kirsi ^b   Bressan, Josefina ^a   Gouveia Peluzio, Maria do Carmo ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Bifidobacteria; Clostridia; Gut microbiota; Insulin; LPS; Obesity

Indexed keywords

INSULIN; LIPOPOLYSACCHARIDE;

ADULT; AKKERMANSIA MUCINIPHILA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BACTERIAL COUNT; BACTERIUM DETECTION; BIFIDOBACTERIUM; BIFIDOBACTERIUM GENUS; BIFIDOBACTERIUM LONGUM; BIOCHEMISTRY; BODY COMPOSITION; BODY MASS; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; LACTOBACILLUS PLANTARUM; LIPID BLOOD LEVEL; NORMAL HUMAN; OBESITY; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; PREVALENCE;

BIFIDOBACTERIA; BMI; BODY MASS INDEX; CLOSTRIDIA; GUT MICROBIOTA; HDL; HIGH DENSITY LIPOPROTEIN; HOMA; HOMEOSTASIS MODEL ASSESSMENT; INSULIN; LDL; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LPS; OBESITY; QPCR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION; TC; TC/HDL; TOTAL CHOLESTEROL; TOTAL CHOLESTEROL/HIGH DENSITY LIPOPROTEIN RATIO;

ADULT; ANTHROPOMETRY; BIFIDOBACTERIUM; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CLOSTRIDIUM; FECES; FEMALE; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; INSULIN; LACTOBACILLUS; LIPOPOLYSACCHARIDES; MICROBIOTA; NUTRITION ASSESSMENT; OBESITY; THINNESS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84887621987     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.02.008     Document Type: Article

References (30)

1. Simmons R., Alberti K., Gale E., Colagiuri S., Tuomilehto J., Qiao Q., et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia 2010, 53(4):600-605.
2. Matthews D., Hosker J., Rudenski A., Naylor B.A., Treacher D.F., Turner R.C., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
3. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005, 25:391-406.
4. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysnfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9(5):367-377.
5. Hamann L., El-Samalouti V., Ulmer A.J., Flad H.-D., Riestschel E.T. Components of gut bacteria as immunomodulators. Int J Food Microbiol 1998, 48(2):141-154.
6. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
7. Pussinen P.J., Havulinna A.S., Lehto M., Sundvall J., Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011, 34(2):392-397.
8. Cani P., Neyrinck A., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50(11):2374-2383.
9. Cani P.D., Possemiers S., Wiele T.V., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58(8):1091-1103.
10. Suzuki T., Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab 2010, 7:19.
11. Moreira A.P.B., Teixeira T.F.S., Ferreira A.B., Peluzio Md.CG., Alfenas Rd.C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108(5):801-809.
12. Teixeira T.F.S., Collado M.C., Ferreira C.L.L.F., Bressan J., Peluzio Md.CG. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012, 32(9):637-647.
13. Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008, 88(4):894-899.
14. Santacruz A., Collado M.C., García-Valdés L., Segura M.T., Martín-Lagos J.A., Anjos T., et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010, 104(1):83-92.
15. Santacruz A., Marcos A., Warnberg J., Martí A., Martin-Matillas M., Campoy C., et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009, 17(10):1906-1915.
16. Holzapfel W.H., Haberer P., Geisen R., Björkroth J., Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 2001, 73(Suppl. 2):365S-373S.
17. Teixeira T.F.S., Souza N.C.S., Chiarello P.G., Franceschini S.C.C., Bressan J., Ferreira C.L.L.F., et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 2012, 31(5):735-740.
18. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. Ahuman gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65.
19. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2009, 18(1):190-195.
20. Ventura M., O'Connell-Motherway M., Leahy S., Moreno-Munoz J.A., Fitzgerald G.F., van Sinderen D., et al. From bacterial genome to functionality: case bifidobacteria. Int J Food Microbiol 2007, 120(1-2):2-12.
21. Lassenius M.I., Pietiläinen K.H., Kaartinen K., Pussinen P.J., Syrjänen J., Forsblom C., et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011, 34(8):1809-1815.
22. Könner A.C., Brüning J.C. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 2011, 22(1):16-23.
23. Laugerette F., Vors C., Peretti N., Michalski M.-C. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 2011, 93(1):39-45.
24. Erridge C., Attina T., Spickett C.M., Webb D.J. Ahigh fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007, 86(5):1286-1292.
25. Brun P., Castagliuolo I., Leo V.D., Buda A., Pinzani M., Palù G., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol 2007, 292(2):G518-G525.
26. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
27. Wang Z., Xiao G., Yao Y., Guo S., Lu K., Sheng Z., et al. The role of bifidobacteria in gut barrier function after thermal injury in rats. JTrauma 2006, 61(3):650-657.
28. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008, 22(7):2416-2426.
29. Hayashi H., Sakamoto M., Kitahara M., Benno Y. Diversity of the Clostridium coccoides group in human fecal microbiota as determined by 16S rRNA gene library. FEMS Microbiol Lett 2006, 257(2):202-207.
30. Furet J.-P., Kong L.-C., Tap J., Poitou C., Basdevant A., Bouillot J.-L., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss. Diabetes 2010, 59(12):3049-3057.